Biotechnology company Bio-Works has received an order worth SEK 2.8 million from a large US biotechnology company developing a new mRNA-based drug. Bio-Works' products and expertise in the purification of biological drugs will be used in the continued development of the drug candidate. The project may expand if drug development proceeds according to plan. The customer's identity is confidential.